{"title":"减肥药物似乎对药物使用障碍患者有益","authors":"","doi":"10.1002/pu.31260","DOIUrl":null,"url":null,"abstract":"<p>Drugs in medication classes commonly used to treat type 2 diabetes and obesity appear to improve substance use outcomes in patients with opioid use disorder (OUD) and alcohol use disorder (AUD), a retrospective cohort study has found. Patients receiving these medications experienced significantly lower rates of opioid overdose and alcohol intoxication. Study results were published online Oct. 16, 2024, in <i>Addiction</i>.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"36 2","pages":"1-5"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Weight-loss drugs appear beneficial for patients with substance use disorders\",\"authors\":\"\",\"doi\":\"10.1002/pu.31260\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Drugs in medication classes commonly used to treat type 2 diabetes and obesity appear to improve substance use outcomes in patients with opioid use disorder (OUD) and alcohol use disorder (AUD), a retrospective cohort study has found. Patients receiving these medications experienced significantly lower rates of opioid overdose and alcohol intoxication. Study results were published online Oct. 16, 2024, in <i>Addiction</i>.</p>\",\"PeriodicalId\":22275,\"journal\":{\"name\":\"The Brown University Psychopharmacology Update\",\"volume\":\"36 2\",\"pages\":\"1-5\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-12-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Brown University Psychopharmacology Update\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/pu.31260\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Brown University Psychopharmacology Update","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/pu.31260","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Weight-loss drugs appear beneficial for patients with substance use disorders
Drugs in medication classes commonly used to treat type 2 diabetes and obesity appear to improve substance use outcomes in patients with opioid use disorder (OUD) and alcohol use disorder (AUD), a retrospective cohort study has found. Patients receiving these medications experienced significantly lower rates of opioid overdose and alcohol intoxication. Study results were published online Oct. 16, 2024, in Addiction.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
